Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Director departure
Appointed director
Quarterly results
CC transcript
MEDIVATION, INC. (MDVN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2015 8-K Acquisition/merger/asset purchase announced
Docs: "Medivation to Expand Global Oncology Franchise with the Acquisition of All Worldwide Rights to Talazoparib , a potent PARP inhibitor, from BioMarin",
"Medivation to Expand Global Oncology Franchise with the Acquisition of All Worldwide Rights to Talazoparib , a potent PARP inhibitor, from BioMarin"
12/20/2004 8-K Acquisition/merger/asset purchase announced, Resignation/termination of a director
Docs: "Agreement and Plan of Merger, by and between Orion Acquisition Corp. II, Medivation Acquisition Corp. and Medivation, Inc",
"Amended and Restated Certificate of Designations of the Series B Convertible Preferred Stock",
"Form of Purchase Agreement",
"Form of Purchase Agreement",
"Form of Registration Rights Agreement",
"Form of Registration Rights Agreement",
"Form of Registration Rights Agreement",
"Contact at Orion Acquisition Corp. II Contact at Medivation, Inc."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy